Brief: Indaptus Therapeutics' Chief Scientific Officer Michael Newman Named A Chair Of 4th Sting & Tlr-Targeting Therapies Summit

Indaptus Therapeutics

01/05/2023 13:17

May 1 (Reuters) - Indaptus Therapeutics Inc  INDP.O :
    * INDAPTUS THERAPEUTICS’ CHIEF SCIENTIFIC OFFICER MICHAEL
NEWMAN,
PH.D. NAMED A CHAIR OF THE 4TH STING & TLR-TARGETING THERAPIES
SUMMIT

Source text for Eikon:  ID:nGNX3Snbxl 
Further company coverage:  INDP.O 

 ((Reuters.Briefs@thomsonreuters.com;))